S.Res. 765

119 SRES 765 ATS: Expressing support for the designation of July 2026 as “National Sarcoma Awareness Month”.
 U.S. Senate
 2026-06-09
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 III  119th CONGRESS  2d Session  S. RES. 765  IN THE SENATE OF THE UNITED STATES   June 9, 2026   Mr. Johnson  (for himself and  Mr. Rounds ) submitted the following resolution; which was considered and agreed to   RESOLUTION
Expressing support for the designation of July 2026 as  National Sarcoma Awareness Month .
Whereas sarcoma is a rare cancer of the bones or connective tissues, such as nerves, muscles, joints, fat, and blood vessels, that can arise nearly anywhere in the body;
Whereas, in the United States—
(1)
about 18,000 individuals are diagnosed with sarcoma each year;
(2)
approximately 7,600 individuals die from sarcoma each year; and
(3)
over 236,000 individuals struggle with sarcoma at any given time;
Whereas, each year, about 1 percent of cancers diagnosed in adults and around 21 percent of cancers diagnosed in children are sarcoma;
Whereas more than 100 subtypes of sarcoma have been identified;
Whereas the potential causes of sarcoma are not well understood;
Whereas treatment for sarcoma can include surgery, radiation therapy, or chemotherapy;
Whereas sarcoma is often misdiagnosed and underreported; and
Whereas July 2026 would be an appropriate month to designate as National Sarcoma Awareness Month—
(1)
to raise awareness about sarcoma; and
(2)
to encourage more individuals in the United States to get properly diagnosed and treated: Now, therefore, be it
That the Senate supports the designation of July 2026 as  National Sarcoma Awareness Month .